From treating a patient’s current disease state to treating based on a patient’s future disease risk, managing IBD has evolved over the years. It was the keynote topic at the AIBD Regional Meeting in Los...
The pipeline for IBD drugs is expanding, with new therapeutics expected over the next several years. The effect these therapies will have on the ulcerative colitis treatment paradigm was discussed at the...
At the 2019 IAS Meeting, Anita Afzali, MD, MPH, from The Ohio State University Wexner Medical Center, discusses current barriers to transitioning a patient with an autoimmune disease from pediatric to adult...
At the 2019 IAS Meeting, Anita Afzali, MD, MPH, from The Ohio State University Wexner Medical Center, discusses current barriers to transitioning a patient with an autoimmune disease from pediatric to adult...
With the aging HIV population, it is important to understand how inflammation and age-related comorbidities will affect treatment options in this population moving forward. This was the topic of Tuesday’s...
With the aging HIV population, it is important to understand how inflammation and age-related comorbidities will affect treatment options in this population moving forward. This was the topic of Tuesday’s...